| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/26/1999 | US5863767 Keratinocyte growth factor fragment lacks the first 23 amino acid residues of the n-terminus of mature, full-length kgf; treatment of hyperproliferative disease of epidermis |
| 01/26/1999 | US5863757 An expression vector comprising polynucleotide having an open reading frame operably linked to a promoter and encoding a specific polypeptide |
| 01/26/1999 | US5863735 Human transmembrane 4 superfamily protein |
| 01/26/1999 | US5863538 Compositions for targeting the vasculature of solid tumors |
| 01/26/1999 | US5863517 Process for the preparation of an organ-specific substance labeled with technetium-99m |
| 01/26/1999 | CA2137639C Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases |
| 01/26/1999 | CA1340342C 17-arylsteroids, process and intermediates for preparing the same, use therof as therapeutic agents and pharmaceutical compositions containing them |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/21/1999 | WO1999002732A1 Antisense oligonucleotide inhibition of ras |
| 01/21/1999 | WO1999002711A2 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | WO1999002701A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002694A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 01/21/1999 | WO1999002686A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002680A1 New human growth regulator protein |
| 01/21/1999 | WO1999002675A1 G-coupled receptor showing selective affinity for atp |
| 01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators |
| 01/21/1999 | WO1999002563A1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002552A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 01/21/1999 | WO1999002550A1 Ctl epitopes from ebv |
| 01/21/1999 | WO1999002514A2 Epothilone derivatives |
| 01/21/1999 | WO1999002510A1 Matrix metalloproteinase inhibitors |
| 01/21/1999 | WO1999002501A1 Novel compounds |
| 01/21/1999 | WO1999002191A1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 01/21/1999 | WO1999002183A2 A method of inducing a ctl response |
| 01/21/1999 | WO1999002180A1 Immunogenic lhrh compositions and methods relating thereto |
| 01/21/1999 | WO1999002177A1 Pharmaceutical composition containing peptichemio |
| 01/21/1999 | WO1999002175A1 Conjugates useful in the treatment of prostate cancer |
| 01/21/1999 | WO1999002167A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 01/21/1999 | WO1999002166A1 Use of colchinol derivatives as vascular damaging agents |
| 01/21/1999 | WO1999002162A1 Cyclin dependent kinase inhibiting purine derivatives |
| 01/21/1999 | WO1999002155A1 Imidazole derivatives as mdr modulators |
| 01/21/1999 | WO1999002143A2 Medicament comprising adenosine |
| 01/21/1999 | WO1998047538A3 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 01/21/1999 | CA2295908A1 New human growth regulator protein |
| 01/21/1999 | CA2295860A1 Conjugates useful in the treatment of prostate cancer |
| 01/21/1999 | CA2295539A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2295149A1 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | CA2294865A1 Immunogenic lhrh compositions and methods relating thereto |
| 01/21/1999 | CA2294752A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2294732A1 Ctl epitopes from ebv |
| 01/21/1999 | CA2294244A1 Cyclin dependent kinase inhibiting purine derivatives |
| 01/21/1999 | CA2265671A1 Matrix metalloproteinase inhibitors |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0891985A1 Process for the production of biologically active protein (e.g. TGF) |
| 01/20/1999 | EP0891770A1 Killer T cell activator and use thereof |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891426A2 Human bikunin |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891377A1 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/20/1999 | EP0891361A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891360A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891357A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891356A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891355A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891353A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891352A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891351A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891350A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891349A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891345A1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 01/20/1999 | EP0891343A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891339A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891337A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891335A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891334A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891331A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity |
| 01/20/1999 | EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891326A1 Novel vitamin d analogues |
| 01/20/1999 | EP0891325A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 01/20/1999 | EP0891187A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
| 01/20/1999 | EP0790986B1 Aniline derivatives |
| 01/20/1999 | EP0767657A4 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 01/20/1999 | EP0764149B1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 01/20/1999 | EP0759986B1 Diagnostics for cancers expressing tyrosine phosphorylated crkl protein |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0641327B1 Novel alpha-mannosidase inhibitors |
| 01/20/1999 | EP0637310B1 Water-soluble retinoids |
| 01/20/1999 | CN1205697A Novel taxoids, prepn. thereof and pharmaceutical compsns. containing same |
| 01/20/1999 | CN1205694A Quinazoline derivatives |
| 01/20/1999 | CN1205328A Sulfonylaminocarboxylic acids |
| 01/20/1999 | CN1205231A Glossy ganoderma preparation and its preparing method |
| 01/20/1999 | CN1205213A Health products able to suppress tumour cell |
| 01/20/1999 | CN1205210A Chinese medicine compositions and preparation for prevention and treatment of cerebrovascular atherosclerosis and cancer |
| 01/19/1999 | US5861515 Esterification of protected baccatin iii or 10-deacetylbaccatin iii using a carboxylic acid substituted oxazolidine, then deprotecting and acylation |
| 01/19/1999 | US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases |
| 01/19/1999 | US5861493 Process for the synthesis of 2'-O-substituted pyrimidines |
| 01/19/1999 | US5861483 Inhibitor of stem cell proliferation and uses thereof |
| 01/19/1999 | US5861436 Inhibitors of the relese of tumor necrosis factor |
| 01/19/1999 | US5861428 Alleviation of osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis bullosa, inflammation, osteopenias, tempero |
| 01/19/1999 | US5861427 Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 01/19/1999 | US5861401 Treatment of congestive heart failure |
| 01/19/1999 | US5861390 Treatment of breast cancer |